Trials / Sponsors / Lion TCR Pte. Ltd.
Lion TCR Pte. Ltd.
Industry · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Cell Carcinoma | Phase 2 | 2025-03-01 |
| Recruiting | Autologous HBV-TCR T Cell Therapy (LioCyx-M) for the Treatment of Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 1 | 2024-06-01 |
| Recruiting | Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV) Hepatocellular Carcinoma | Phase 1 | 2022-05-20 |
| Withdrawn | A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation Recurrent Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2018-08-01 |
| Completed | A Study of TCR-Redirected T Cell Infusion to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplant Hepatocellular Carcinoma | Phase 1 | 2018-05-16 |
| Unknown | A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation Recurrent Hepatocellular Carcinoma | Phase 1 | 2015-07-02 |